Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
about
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores"Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.Pre-exposure prophylaxis for HIV prevention in women: current perspectivesPerceived Advantages and Disadvantages of Using Pre-Exposure Prophylaxis (PrEP) among Sexually Active Black Women: An Exploratory Study.Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV.Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities.A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.Women want Pre-Exposure Prophylaxis but are Advised Against it by Their HIV-positive CounterpartsThe Potential of Pre-Exposure Prophylaxis for Women in Violent RelationshipsHIV pre-exposure prophylaxis for women.Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States, 2015.A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective"Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation.Raising Awareness of Pre-Exposure Prophylaxis (PrEP) among Women in New York City: Community and Provider Perspectives.State of HIV in the US Deep South.Reaching Key Populations: PrEP Uptake in an Urban Health Care System in the Bronx, New York.Attitudes Toward HIV Pre-Exposure Prophylaxis in a United States Urban Clinic Population.HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami.Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients.Knowledge, Stereotyped Beliefs and Attitudes Around HIV Chemoprophylaxis in Two High HIV Prevalence Neighborhoods in New York City.HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.Couples Living with HIV.Top Questions in ID: Pre-exposure Prophylaxis for HIV.Awareness, Interest, and HIV Pre-Exposure Prophylaxis Candidacy Among Young Transwomen.PrEP Implementation Science: State-of-the-Art and Research Agenda.Adolescent pre-exposure prophylaxis for HIV prevention: current perspectives.Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women.Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.Factors associated with perceived accuracy of the Undetectable = Untransmittable slogan among men who have sex with men: Implications for messaging scale-up and implementation.Leveraging Social Media to Explore Black Women's Perspectives on HIV Pre-exposure Prophylaxis.Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.U.S. Guidelines that empower women to prevent HIV with pre-exposure prophylaxis: Women and PrEP Guidelines.Family planning providers' role in offering PrEP to women.Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States.HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system.
P2860
Q26798250-846622C3-578C-4821-A618-AA9B4D8BEB1EQ32174089-ED8F8E47-BA9A-40E4-9877-9183482727EEQ33656112-A6A6AAD2-395C-428A-9A01-C387C48DE451Q33658647-D83DA789-7B0B-489C-99A3-827307D66EEFQ33766562-B75E6B90-FD6B-4AF8-AD8F-7143099CFCA8Q33908319-FF67A10B-4D75-472D-ABE1-597F12399948Q35875729-FF0D1699-1E93-417B-B3DB-6BC5B574B984Q36006842-2C0478EE-93F8-4E54-A7E9-C4A6A461CB39Q36053059-3C688874-47AA-4DF3-B0A0-ED3D6CEBC005Q36204808-AAA6918B-54B0-4C6F-929C-E210924FC0C9Q36294782-234F5FCD-9BDD-4707-80C7-05BD7BD79589Q36728424-F6728591-D1E6-4E79-BC3C-66236164C31FQ37019969-B1ECDAB0-93B6-42E4-A648-2625EA2C37E3Q37141403-2C291A1E-6CE0-491B-9FDF-FC1F97141936Q37736077-48C7D7BA-E210-40FA-B3E3-5642D3FC7DC5Q38611532-911901E5-7896-4DE3-963F-765537A2C2DAQ38672579-972330EA-0070-44F2-8170-670EF89C1044Q38834636-17705C01-8DB1-42E6-8095-30AC5A0DBA4EQ38935875-1FED3E1A-24A0-404E-93E6-D3D7FDB34BB5Q38936501-6E73589C-5F95-4E19-888E-BEDD7D33EEC9Q39057207-74F526FF-2F38-40BF-8093-F483AF9273B2Q39821223-40EDE56E-7763-4AC4-B639-5A5A739F81CFQ40524587-DFFE21E4-8B00-4F4A-9A1B-C045C8186157Q40524839-F3D3C217-19F6-48DC-A64E-A61952F07095Q40675216-E795BB41-9A2F-4F91-A607-B5E993BFA7E0Q40777604-DF96D84F-9101-45F9-9E80-746FB05337DEQ40952549-F5592A02-B9A1-4989-82C9-BB24307A0AEEQ42271267-118A491C-EF61-4CCF-AD42-EC0044F39BA4Q42908254-55FB7BFC-5298-42BB-A049-F40286E4031DQ43241737-11FB8AB2-3C96-4B57-A031-70B22C8EF48AQ46540207-63B18D06-113F-40B6-A07E-7AC8D0800D82Q47105640-5376D4B6-6F68-415E-B4AF-ED62A7B26438Q47395860-331857E1-B965-440C-AD4B-48843CBB478DQ47553656-E3E9F411-C832-47A7-87EF-B27754AA41D7Q47781774-8B88DBF0-CC16-411A-9531-EC17AF6AF046Q49382513-BF36E710-601A-4474-9F39-C2F90514FF82Q49711628-3BE7EDCA-6FA4-486B-B118-AF46AEBFA0D3Q50168442-0B976DB0-6BB8-4599-A7F3-C049B634A6C3Q50224009-14C7BD8B-AFCF-4DFF-8D3E-9D5D19B2D6F6Q52661345-89CA36B2-1AD2-47E5-872B-8F76AE75DAB0
P2860
Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Knowledge, attitudes, and like ...... omen at risk of acquiring HIV.
@ast
Knowledge, attitudes, and like ...... omen at risk of acquiring HIV.
@en
type
label
Knowledge, attitudes, and like ...... omen at risk of acquiring HIV.
@ast
Knowledge, attitudes, and like ...... omen at risk of acquiring HIV.
@en
prefLabel
Knowledge, attitudes, and like ...... omen at risk of acquiring HIV.
@ast
Knowledge, attitudes, and like ...... omen at risk of acquiring HIV.
@en
P2093
P2860
P356
P1476
Knowledge, attitudes, and like ...... women at risk of acquiring HIV
@en
P2093
Gina Brown
Judith D Auerbach
Vignetta Charles
P2860
P304
P356
10.1089/APC.2014.0142
P577
2014-12-16T00:00:00Z